|
HEATR3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.397780E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.553500E-02 |
| Normal-vs-Stage2 |
4.454000E-02 |
| Normal-vs-Stage3 |
7.413000E-01 |
| Normal-vs-Stage4 |
9.004000E-01 |
| Stage1-vs-Stage2 |
4.516000E-01 |
| Stage1-vs-Stage3 |
1.469440E-01 |
| Stage1-vs-Stage4 |
2.018200E-01 |
| Stage2-vs-Stage3 |
9.183700E-02 |
| Stage2-vs-Stage4 |
9.588000E-02 |
| Stage3-vs-Stage4 |
8.768600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.280560E-01 |
| Normal-vs-AfricanAmerican |
9.962400E-01 |
| Normal-vs-Asian |
3.862600E-01 |
| Caucasian-vs-AfricanAmerican |
3.769000E-01 |
| Caucasian-vs-Asian |
8.768600E-01 |
| AfricanAmerican-vs-Asian |
5.019000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.256000E-01 |
| Normal-vs-Female |
1.051760E-01 |
| Male-vs-Female |
4.482600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.104240E-01 |
| Normal-vs-Age(41-60Yrs) |
5.176400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.018620E-01 |
| Normal-vs-Age(81-100Yrs) |
5.893600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.355600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.896600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.464400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.007800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.499200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.749200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.022000E-01 |
| Classical-VS-Follicular |
2.478200E-01 |
| Classical-VS-Other |
6.182000E-02 |
| Classical-VS-Normal |
4.153500E-02 |
| Tall-VS-Follicular |
8.068000E-01 |
| Tall-VS-Other |
2.232600E-01 |
| Tall-VS-Normal |
7.565400E-01 |
| Follicular-VS-Other |
1.697820E-01 |
| Follicular-VS-Normal |
4.663800E-01 |
| Other-VS-Normal |
1.738620E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.295830E-01 |
| Normal-vs-N1 |
4.617800E-01 |
| N0-vs-N1 |
4.141800E-02 |
|
|
